Recently, the project “Development and Industrial Application of Key Technologies for Digital and Intelligent Integration in Biopharmaceutical Equipment”, jointly submitted by Shanghai Morimatsu Pharmaceutical Equipment Engineering Co., Ltd. (hereinafter “Morimatsu”) and Shanghai Institute of Computing Technology Co., Ltd., won the CIIF High-Tech Engineering Award at the 26th China International Industry Fair (CIIF). The award recognizes Morimatsu’s innovation and engineering expertise in integrating digital and intelligent technologies into biopharmaceutical equipment.

About the CIIF High-Tech Engineering Award

The China International Industry Fair (CIIF) is a major national industrial exhibition in China, recognized for its scale, professional standing, and industry influence. Its awards attract entries from around the world and emphasize international participation, high standards, and diversity. Often described as the “Oscars” of China’s industrial sector, the CIIF Awards recognize outstanding industrial innovation. The CIIF High-Tech Engineering Award is a core professional award of the fair and focuses on advances in large-scale engineering systems and equipment, with an emphasis on original technological breakthroughs, practical engineering applications, and industrial demonstration value.

As the biopharmaceutical industry moves toward larger-scale and more intelligent manufacturing, demand is growing for more efficient, reliable, and digitally enabled production equipment and engineering systems. However, several challenges remain in biopharmaceutical engineering:

· Insufficient translation of laboratory-scale process knowledge into large-scale equipment design;

· Limited systematic decomposition of complex processes into functional modules and corresponding engineering structures;

· Difficulties in preserving and applying design and construction information throughout equipment operation and maintenance.

These gaps hinder efficient scale-up, reliable project delivery, and the continuous optimization of complex biopharmaceutical systems.

Digital and Intelligent Integration Drives End-to-End Collaborative Innovation

To address these industry challenges, Morimatsu has leveraged its extensive experience in pharmaceutical equipment design and manufacturing, as well as modular plant project delivery, to conduct systematic R&D in digital and intelligent integration for biopharmaceutical equipment. The project has developed an integrated suite of solutions spanning a digital and intelligent platform, process scale-up and precision control methods, large-scale bioreactor equipment, a digital and intelligent construction system for modular biopharmaceutical plants, and a full-lifecycle operations and maintenance platform. Together, these solutions shift the focus from optimizing individual equipment functions to coordinating the entire process, equipment, engineering, and operations and maintenance workflow. They strengthen Morimatsu’s capabilities in independent development of large-scale core equipment, complex engineering system integration, and large-scale international project delivery.

The project’s results have already been implemented commercially at biopharmaceutical companies, improving production efficiency, product quality consistency, and operational management. They also offer practical engineering solutions that can serve as models for digital transformation and intelligent upgrading across the biopharmaceutical industry.

This award recognizes Morimatsu’s strengths in digital and intelligent innovation and engineering implementation. Looking ahead, Morimatsu will continue to foster collaboration among industry, academia, and research institutions, further integrate emerging information technologies such as artificial intelligence into pharmaceutical equipment and modular plants, and support the biopharmaceutical industry’s high-quality development with advanced equipment and integrated digital and intelligent solutions.

About Morimatsu LifeSciences

Morimatsu LifeSciences is a key business segment of Morimatsu International Holdings Limited (Stock Code: 2155.HK). It comprises Shanghai Morimatsu Pharmaceutical Equipment Engineering Co., Ltd., Morimatsu (Suzhou) LifeSciences Co., Ltd., Shanghai Morimatsu Biotechnology Co., Ltd., Shanghai Mori-Biounion Technology Co., Ltd., Shanghai Morisora Technology Co., Ltd., Bioengineering AG, Pharmadule Morimatsu AB, and its affiliated companies.

Morimatsu LifeSciences is dedicated in providing core equipment, process systems, and smart modular facility solutions, and services for the pharmaceutical, biopharmaceutical, medical aesthetics, and fast-moving consumer goods (FMCG) sectors including (cosmetics, food, and health supplements), as well as data centers.

Our team comprises highly experienced professionals with deep expertise in process R&D, engineering design, advanced manufacturing, compliance and validation consulting, production execution, and intelligent operations. With broad experience across diverse industries, we fully understand the unique characteristics and process requirements of various products. This enables us to deliver tailored, end-to-end process solutions from the conceptual design stage, precisely aligned with client’s specific needs.

Morimatsu LifeSciences has established a strong global presence, supported by advanced R&D centers, design hubs, and state-of-the-art manufacturing facilities worldwide. Our well-established service network spans Europe,USA,Asia-Pacific, and emerging markets. We have successfully delivered outstanding, customized solutions to clients in over 40 countries and regions, gaining extensive experience in international project execution.

As a multinational enterprise with core strengths in process technology, modular facility construction, and intelligent manufacturing, Morimatsu LifeSciences is dedicated to meeting the evolving equipment and system needs of our key industries. Through continuous innovation and technological advancement, we are steadily expanding our global footprint, driving our international strategy forward, and delivering Morimatsu’s expertise, reliability, and innovation to the global life sciences and related sectors.